Relationship between placebo response rate and clinical trial outcome in bipolar depression.

/in /by

Iovieno N, Nierenberg AA, Parkin SR, Hyung Kim DJ, Walker RS, Fava M, Papakostas GI.

J Psychiatr Res. 2016 Mar;74:38-44. doi: 10.1016/j.jpsychires.2015.12.016. Epub 2015 Dec 20.

The role of regulators, investigators, and patient participants in the rise of the placebo response in major depressive disorder. World Psychiatry.

/in /by

Fava M.

2015 Oct;14(3):307-8. doi: 10.1002/wps.20247.

The nature of placebo response in clinical studies of major depressive disorder.

/in /by

Papakostas GI, Østergaard SD, Iovieno N.

J Clin Psychiatry. 2015 Apr;76(4):456-66. doi: 10.4088/JCP.14r09297.

Predictors of placebo response in bipolar depression.

/in /by

Nierenberg AA, Østergaard SD, Iovieno N, Walker RS, Fava M, Papakostas GI.

Int Clin Psychopharmacol. 2015 Mar;30(2):59-66. doi: 10.1097/YIC.0000000000000058.

Updates and trends in the treatment of major depressive disorder.

/in /by

Papakostas GI, Ionescu DF.

J Clin Psychiatry. 2014 Dec;75(12):1419-21. doi: 10.4088/JCP.14ac09610.

Correlation between different levels of placebo response rate and clinical trial outcome in major depressive disorder: a meta-analysis.

/in /by

Iovieno N, Papakostas GI.

J Clin Psychiatry. 2012 Oct;73(10):1300-6. doi: 10.4088/JCP.11r07485. Review.